A Malaysian patient with a complex tumor history wanted to understand whether specialized local-control technologies or immune-based treatment could be discussed with specialists. The family needed a structured comparison instead of isolated treatment names.
Fokus persiapan
Turning technology interest into clinical questions
The family had heard about proton therapy, interventional oncology, NanoKnife, iodine-125 seed implantation, cryoablation, and biological immunotherapy. Novacare helped frame these as suitability questions linked to tumor anatomy and prior therapy.
- Origin
- Malaysia
- Focus
- Precision oncology technologies
- Output
- Specialist-ready review file
Technology review framework
Imunoterapi biologis
Immune status, PD-1 / PD-L1 background, prior systemic treatment, cell-based options, combination strategy, and recurrence-risk management.
Terapi proton
Potential value of dose distribution and organ protection for selected tumor sites where conventional radiation risk requires review.
Onkologi intervensional
Questions around arterial infusion, embolization, localized drug delivery, tumor vascularity, and liver-dominant disease control.
NanoKnife / IRE
Feasibility questions for lesions near vessels, bile ducts, pancreatic structures, or other sensitive anatomy.
Iodine-125 brachytherapy
Discussion points around local implantation, dose planning, lesion accessibility, and post-procedure monitoring.
Krioablasi
Questions around tumor size, location, imaging guidance, local-control objective, and combination with systemic therapy.
Information required before specialist communication
- Latest contrast-enhanced imaging and DICOM files, not only screenshot images.
- Clear pathology diagnosis and staging history, including recurrence or metastasis details.
- Previous treatment timeline, response assessment, toxicity history, and current medication list.
- Performance status, pain level, nutrition status, blood results, and organ-function indicators.
- The family’s preferred goal: local control, symptom relief, recurrence-risk management, or further systemic treatment planning.
Service path
- Technology list cleanup: Treatment names were grouped by purpose instead of presented as a menu.
- Clinical file mapping: Each technology question was linked to anatomy, imaging, pathology, and previous treatment exposure.
- Consultation preparation: The family received a concise question set for physician review.
- Travel planning boundary: Novacare clarified which points could be discussed remotely and which required in-person examination.